The lncRNA 44s2 Study Applicability to the Design of 45-55 Exon Skipping Therapeutic Strategy for DMD.
Gargaun E, Falcone S, Solé G, Durigneux J, Urtizberea A, Cuisset JM, Benkhelifa-Ziyyat S, Julien L, Boland A, Sandron F, Meyer V, Deleuze JF, Salgado D, Desvignes JP, Béroud C, Chessel A, Blesius A, Krahn M, Levy N, Leturcq F, Pietri-Rouxel F.
Gargaun E, et al. Among authors: falcone s.
Biomedicines. 2021 Feb 20;9(2):219. doi: 10.3390/biomedicines9020219.
Biomedicines. 2021.
PMID: 33672764
Free PMC article.